FUL.L Regulatory News (FUL)

6 Nov 2007 07:01

Fulcrum Pharma PLC06 November 2007 FULCRUM PHARMA PLC ("the Group" or "the Company") Official Opening of Ann Arbor Office to Serve Growing US Customer Base Fulcrum Pharma plc (AIM: FUL), the drug development and strategic outsourcingservices company, is pleased to announce that it has opened an office in AnnArbor, Michigan as part of the Group's planned expansion. The Ann Arbor office, which is located at 900 Victors Way, Suite 160, Ann Arbor,MI 48108, will complement Fulcrum's other US office in Research Triangle Park,North Carolina, and will allow the Group to further develop the depth of theGroup's resources in drug development, project management and regulatoryaffairs. Fulcrum operates six other offices throughout the EU and Japan. Staff recruitment has already begun at the Ann Arbor office and Fulcrum isbenefiting from the pool of experienced talent in the region enabling it torecruit drug development staff with considerable experience. The Ann Arboroffice will focus on early drug development services, with emphasis onpreclinical development. The opening of the Ann Arbor office represents another significant milestone inthe Group's planned expansion, which is seeing Fulcrum increase both the rangeof its services and the volume of work it is able to carry out for itsinternational client base. Jon Court, Chief Executive of Fulcrum Pharma, said: "The opening of the Ann Arbor office is another demonstration of our commitmentto the US Market and our provision of drug development services to thebiotechnology and pharmaceutical industries. It will enable us to provide aneven more efficient service to our customers." FOR FURTHER INFORMATION, PLEASE CONTACT: Fulcrum Pharma PLCJon Court, Chief Executive Tel: 0870 710 7152 Seymour PierceJonathan Wright Tel: 0207 107 8000 About Fulcrum Pharma plc Fulcrum Pharma plc is a drug development and regulatory services business thatprovides global expertise to achieve drug development and regulatory approvalmilestones. Fulcrum Pharma offers immediate access to a highly credible, integrateddevelopment team that provides strategic and operational leadership required toensure that new drugs move smoothly from discovery research to product approval Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange The following can be used for a trade press announcement About Fulcrum Pharma plc Fulcrum Pharma plc is a drug development and regulatory services business thatprovides global expertise to achieve drug development and regulatory approvalmilestones. Fulcrum Pharma offers immediate access to a highly credible, integrateddevelopment team that provides strategic and operational leadership required toensure that new drugs move smoothly from discovery research to product approval Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange This information is provided by RNS The company news service from the London Stock Exchange